3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Radiodermatitis
1
Papillomavirus Infections
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lung Neoplasms
1
Localized Prostate Carcinoma
1
Leukemia, Myeloid, Acute
1
Hepatitis B
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Endometrial Clear Cell Adenocarcinoma
1
Disease Progression
1
Interventions
Paclitaxel
19
pembrolizumab
16
Carboplatin
12
Bevacizumab
8
lenvatinib
6
rucaparib
5
Nivolumab
5
Megestrol Acetate
5
Radiation
4
Indocyanine Green
4
Gemcitabine
4
Cisplatin
4
tisotumab vedotin
3
temsirolimus
3
Sirolimus
3
Sentinel Lymph Node Biopsy
3
Magnetic Resonance Spectroscopy
3
Doxorubicin
3
olaparib
2
niraparib
2
ixabepilone
2
iso-sulfan blue
2
irosustat
2
epacadostat
2
durvalumab
2
copanlisib
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Endometrial Neoplasms
×
Practice Guidelines as Topic
×
Clear all
No trials found.